Connecticut Clinical Trials

A listing of Connecticut clinical trials actively recruiting patient volunteers.

A tiny state full of important American history, Connecticut was essential to many of the major events of the Revolutionary War. These days, it enjoys a slower pace of life in communities like the capital Hartford, New Haven, Stamford, and Bridgeport. New Haven is famed as the home of Yale University, one of the cornerstones of the prestigious Ivy League. Connecticut’s highly educated population also takes its healthcare very seriously: It has an outsized impact on the nation’s health-related research. The #1 hospital in the state is Yale New Haven Hospital, with 1,549 staffed beds and very positive patient reviews.

Filter by Condition
1263 trials found

Modified Ketogenic Diet and Ketamine for Anorexia Nervosa


Pilot Study of Adult Participants with Chronic Anorexia Nervosa to Measure Lessening of Anorexic Thoughts and Behavior, Including Mood, Eating Behavior and Exercise Compulsion By Eating a Modified Ketogenic Diet for 4-8 Weeks Followed By 3-6 Ketamine Infusions

Conditions: Anorexia Nervosa

Gender Related Differences in the Acute Effects of Delta-9-Tetrahydrocannabinol in Healthy Humans: Sub-Study II


The purpose of the study is to characterize the acute effects of cannabinoids in women relative to men and to begin probing the mechanisms that may underlie gender differences.

Conditions: Cannabis

Efficacy Trial of the CALM Intervention


Excessive anxiety among elementary students is highly prevalent and associated with impairment in academic, social, and behavioral functioning. The primary aim of this project is to evaluate the initial efficacy of a brief nurse-delivered intervention (CALM: Child Anxiety Learning Modules), relative to a credible comparison (CALM-R, relaxation skills only) and a waitlist control for reducing anxiety symptoms and improving education outcomes at post intervention and at a 1-year follow-up. In addi ...

Conditions: Anxiety Disorder of Childhood
Phase: Not Applicable

Efficacy and Safety of ETX-018810 for the Treatment of Diabetic Peripheral Neuropathic Pain


A Randomized, Double-Blind, Placebo-Controlled, Multicenter, Parallel-Group Study to Evaluate the Efficacy and Safety of ETX 018810 in Subjects with Diabetic Peripheral Neuropathic Pain.

Conditions: Diabetic Peripheral Neuropathic Pain, Diabetic Peripheral Neuropathy

Efficacy and Safety of Belumosudil in Subjects With Diffuse Cutaneous Systemic Sclerosis


This is a phase 2, open-label, single-cohort, multicenter trial of belumosudil in subjects with Diffuse Cutaneous Systemic Sclerosis (dcSSc). An estimated total of 12 to 15 subjects will receive belumosudil 200 mg administered orally (PO) twice daily (BID) for 52 weeks. The primary analysis will be at 24 weeks.

Conditions: Diffuse Cutaneous Systemic Sclerosis

Physical Activity To Heal Back Pain


This study will advance understanding on the mechanisms that mediate improved outcomes for chronic low back pain and provide specific directions for optimizing physical activity interventions for this population.

Conditions: Chronic Low Back Pain
Phase: Not Applicable

Efficacy and Safety of Tolperisone in Subjects With Pain Due to Acute Back Muscle Spasm


This is a double-blind, randomized, placebo-controlled, multicenter study of the efficacy and safety of tolperisone (a non-opioid) or placebo administered in subjects with pain due to acute back muscle spasm.

Conditions: Back Muscle Spasm, Back Pain, Back Strain, Back Spasm Upper, Muscle Spasm, Acute Pain

Multifactorial Risk Assessment for Breast & Ovarian Cancer Risk Detection


The objective of this project is to validate a next-generation assay that utilizes both the protein biomarkers of our already established ovarian cancer risk assessment combined with a molecular profile in both germline and early somatic detection.

Conditions: Adnexal Mass, Germline BRCA1 Gene Mutation, Germline BRCA2 Gene Mutation, Hereditary Breast and Ovarian Cancer

ASCO Survey on COVID-19 in Oncology (ASCO) Registry


The American Society of Clinical Oncology (ASCO) Survey on Coronavirus 2019 (COVID-19) in Oncology Registry (ASCO Registry) aims to help the cancer community learn more about the patterns of symptoms and severity of COVID-19 among patients with cancer, as well as how COVID-19 is impacting the delivery of cancer care and patient outcomes. The ASCO Registry is designed to collect both baseline and follow-up data on how the virus impacts cancer care and cancer patient outcomes during the COVID-19 p ...

Conditions: Neoplasms, Coronavirus

Study of Cobolimab in Combination With Dostarlimab and Docetaxel in Advanced NSCLC Participants


This is a multi-center, parallel group treatment, Phase 2 open label study evaluating cobolimab in combination with dostarlimab and docetaxel in participants with advanced Nonsmall cell Lung Cancer (NSCLC) who have progressed on prior anti-PD-(L)1 therapy and chemotherapy.

Conditions: Lung Cancer, Non-Small Cell

Risk Factors That Contribute to the Maintenance of Sinus Rhythm


This is a prospective clinical research study. The objective of this study is to evaluate if clinical risk factors as well as structural features on echocardiography affect the maintenance of sinus rhythm after electrical cardioversion at 30 days. We anticipate 140 patients to be enrolled in the study.

Conditions: Atrial Fibrillation

Behavior Therapy for Irritability in Autism


This is a clinical trial of a novel intervention, Behavioral Therapy for Irritability and Aggression (BTIA), for adolescents on the autism spectrum. The main goals of BTIA are to help adolescents develop emotion regulation skills to handle frustration and to strengthen skills for navigating the challenging and diverse experiences associated with the transition to adulthood. The study will test whether BTIA can be helpful to adolescents on the autism spectrum and to their families.

Conditions: Autism Spectrum Disorder, Irritability, Disruptive Behavior, Anger, Aggression, Asperger Syndrome, Pervasive Developmental Disorder
Phase: Not Applicable